Glycomic immunotherapies

Nature appears to have taken full advantage of the vast diversity of glycans expressed in organisms by evolving protein modules to recognize discrete glycans that mediate specific physiological or pathological processes. Excluding glycan-specific antibodies, GBPs broadly into two major groups such as lectins and glycosaminoglycan-binding proteins. Most lectins are members of families with defined “carbohydrate-recognition domains” (CRDs) that apparently evolved from shared ancestral genes, often retaining specific features of primary amino acid sequence or three-dimensional structure. Thus, new family members can be identified by searching protein sequence or structural databases.

    Related Conference of Glycomic immunotherapies

    July 13-14, 2018

    13th International Conference on Structural Biology

    Toronto | Ontario | Canada
    15-16 August 2018

    16th Asia Pacific Biotechnology Congress

    Singapore
    August 16-17, 2018

    5th Annual Congress on Plant & Soil Science

    London, UK
    August 27-28, 2018

    5th International Conference on Glycobiology, Lipids & Proteomics

    Toronto, Ontario, Canada
    August 27-28, 2018

    3rd International Conference on Molecular Biology & Nucleic Acids

    Toronto, Ontario, Canada
    September 17-19, 2018

    4th Glycobiology World Congress

    Rome, Italy
    September 24-26, 2018

    14th International Conference on Structural Biology

    Berlin, Germany
    October 03-04, 2018

    4th International Conference on Biochemistry & Biophysics

    Los Angeles, California, USA
    Nov 19-20, 2018

    15th World Congress on Structural Biology

    Lisbon, Portugal
    December 05-06, 2018

    4th International Conference on Genetic and Protein Engineering

    Chicago, Illinois, USA

    Glycomic immunotherapies Conference Speakers